Rifamicina

Rifamicina Adalvo 200 MG Comprimidos de Liberacion Modificada

200 mg comprimido de liberación modificadaSpainMarketedAuthorised 28 Jun 2019

In other countries

The same active substances on other registers, the same brand first.

Packs

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Rifamicina

Rifamicina Adalvo 200 MG Comprimidos de Liberacion Modificada

200 mg comprimido de liberación modificadaSpainMarketedAuthorised 28 Jun 2019

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Packs

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Rifamicina
Strength: 200 mg
Dosage form: comprimido de liberación modificada
Route: vía oral
Register: Spain (AEMPS)
Status: Marketed
Status in the register: Autorizado, comercializado
Authorised: 28 Jun 2019
Registration: 84120
Marketing authorisation holder: Adalvo Competence Center S.R.L.
Procedure: National, MRP or DCP
Supply: Medicamento Sujeto A Prescripción Médica